Loading organizations...
Key people at PTX Capital.
PTX Capital is a Baltimore-based private investment firm focused on the healthcare and life sciences sectors. The firm employs a venture capital approach, partnering with innovative businesses to develop solutions and technologies that advance the future of medicine. Its strategic focus lies in fostering impactful growth within the health industry.
Established in 2021, PTX Capital was founded by principals including Managing Partner Matt Hellauer. The firm emerged from recognizing significant opportunities within the evolving healthcare landscape, aiming to deploy capital into promising enterprises. This insight centered on enabling visionary entrepreneurs to address critical needs and drive medical advancements.
PTX Capital primarily serves entrepreneurs and emerging companies within the healthcare and life sciences ecosystems, providing investment to scale operations and accelerate development. The firm envisions itself as a vital partner in shaping a healthier future, empowering a portfolio of companies dedicated to enhancing patient care and fostering widespread health innovation.
Key people at PTX Capital.
PTX Capital has 4 tracked investments across 3 companies. The latest tracked deal is $9.0M Series A in Pair Team in October 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 19, 2023 | Pair Team | $9.0M Series A | Julian Eison | JAY Desai, Chas Pulido, Augment Ventures, California Health Care Foundation, Create Health Ventures, Kapor Capital, Kleiner Perkins, OCA Ventures, Y Combinator |
| Apr 12, 2023 | Scene Health | $17.7M Series B | CAL Wheaton | Claritas Health Ventures, Healthworx, Kapor Capital |
| Jul 1, 2022 | Delfi Diagnostics | $230.0M Series B | Justin KAO | Canvas Ventures, DFJ Growth, Jenny Fielding, Scott Hartley, Menlo Ventures, OrbiMed, Westlake Village BioPartners, AV8 Ventures, Brown Advisory, Cowen Healthcare Investments, ELI Lilly And Company, Foresite Capital, Illumina Ventures, Initiate Ventures, Anthology Fund, Northpond Ventures, Open Field Capital, Point72, Point Field Partners, Rock Springs Capital, Samsara BioCapital, T. Rowe Price Associates, Windham Venture Partners |
| May 19, 2021 | Scene Health | $6.2M Series A | Theresa Sexton | CareFirst BlueCross BlueShield, Doba Parushev, Kapor Capital, TCP Venture Capital |